diagnostic announcement to relatives of patients with schizophrenia

Conditions: Schizophrenia

Summary: the diagnostic announcement of a chronic disorder is an essential step in the patient's care. recommendations specify the importance of including caregivers at the time of the announcement. in practice, caregivers are not systematically associated with the announcement of the diagnosis of schizophrenia, while the daily support of patients is provided in 75% of cases by the family. this support can lead to the exhaustion of caregivers and have repercussions on their sick loved one. this study will qualitatively describe and explore the experience of the diagnostic announcement in relatives of patients with schizophrenia. specifically, the investigators will explore the history before the diagnosis is announced, the conditions of the announcement and the experiences of relatives as well as the impact at the personal and family-levels. this study will also explore the expectations of caregivers and avenues for reflection for announcement of schizophrenia diagnosis. the number of subjects to be included in this study is therefore set at 30. a preselection of each potential participant will be carried out by phone or in person to ensure the presence of inclusion criteria and the absence of non-inclusion criteria. the patients will also be provided with oral information about the study to allow sufficient time to reflect before inclusion. then, the selection-inclusion-interview visit will take place visually in an intra-hospital or extra-hospital consultation structure of the center hospitalier alpes-isère. this visit will be unique and will consist of the entire protocol. it will be both a selection, inclusion and interview visit. once the results have been analyzed, this study will provide a better understanding of the experiences of relatives of patients when the diagnosis of schizophrenia is announced, the impact of this announcement on caregivers and family relationships and the expectations of caregivers regarding this announcement. in the long term, the data collected will be add value in developing medical recommendations on consultation to announce the diagnosis of schizophrenia to relatives of patients, in order to best meet the expectations of relatives and to minimize as much as possible the harmful impact that can have such announcement.

schizophrenia is a psychiatric disorder that affects 1% of the population worldwide. the diagnostic announcement of this chronic disorder is an essential step in the patient's care. recommendations specify the importance of including caregivers at the time of the announcement. in practice, caregivers are not systematically associated with the announcement of the diagnosis of schizophrenia, while the daily support of patients is provided in 75% of cases by the family. this support can lead to the exhaustion of caregivers and have repercussions on their sick loved one. this study will qualitatively describe and explore the experience of the diagnostic announcement in relatives of patients with schizophrenia. specifically, the investigators will explore the history before the diagnosis is announced, the conditions of the announcement and the experiences of relatives as well as the impact at the personal and family-levels. this study will also explore the expectations of caregivers and avenues for reflection for announcement of schizophrenia diagnosis. the number of subjects to be included in this study is therefore set at 30. a preselection of each potential participant will be carried out by phone or in person to ensure the presence of inclusion criteria and the absence of non-inclusion criteria. the patients will also be provided with oral information about the study to allow sufficient time to reflect before inclusion. then, the selection-inclusion-interview visit will take place visually in an intra-hospital or extra-hospital consultation structure of the center hospitalier alpes-isère. this visit will be unique and will consist of the entire protocol. it will be both a selection, inclusion and interview visit. once the results have been analyzed, this study will provide a better understanding of the experiences of relatives of patients when the diagnosis of schizophrenia is announced, the impact of this announcement on caregivers and family relationships and the expectations of caregivers regarding this announcement. in the long term, the data collected will be add value in developing medical recommendations on consultation to announce the diagnosis of schizophrenia to relatives of patients, in order to best meet the expectations of relatives and to minimize as much as possible the harmful impact that can have such announcement.

Eligibility criteria:
inclusion criteria: * family member of the 1st or 2nd degree of a person: * with a diagnosis of schizophrenia or schizoaffective disorder according to the criteria of the m.i.n.i. (mini international neuropsychiatric interview) based on dsm-5 (diagnostic and statistical manual of mental disorders) * whose diagnosis of schizophrenia or schizoaffective disorder was announced during a consultation with a psychiatrist less than 2 years ago. * able to read, understand and speak the french language * consent to the study and able to sign no objection exclusion criteria: * presence of schizophrenia or a schizoaffective disorder * guardianship measure or safeguard of justice * agitation or major risk of suicide * refusal to participate in the study